InvestorWire NewsRoom


Brain Scientific Inc. (BRSF) Launches Latest Version of NeuroCap at Largest Global Conference for Neuro Specialists
December 30, 2020

Brain Scientific Inc. (BRSF) Launches Latest Version of NeuroCap at Largest Global Conference for Neuro Specialists

  • BRSF presented a new version of NeuroCap(TM), a revolutionary disposable EEG headset
  • Latest version presented to international medical audience includes velcro enhancements for better adhesion
  • Brain Scientific appears well placed to capitalize on growing need for neurodiagnostic procedures

Brain Scientific (OTCQB: BRSF) a neurology-focused medical device company, presented updates on its proprietary brain diagnostics technology at AES2020, the virtual annual meeting of the American Epilepsy Society, the world’s largest scientific meeting focused on epilepsy and clinical neurophysiology. BRSF released the latest version of its disposable electroencephalogram (“EEG”) device in October 2020: the NeuroCap with velcro enhancements, which provide better adhesion, ensuring easy application by any medical professional.

NeuroCap may provide significant benefits to healthcare providers because it can be easily applied without special training. The demand for EEG testing has been growing, but specialized EEG technologists are needed to perform the traditional diagnostic procedure. With NeuroCap, any clinical staff, including nurses and medical assistants can apply EEG cap in five minutes or less to expedite the EEG testing.

EEG testing is essential in medical care for patients diagnosed with epilepsy. Although almost 4% of people in the United States are diagnosed with epilepsy, BRSF data indicate that only 254 of 6,210 hospitals are level 4 epilepsy centers, which are medical facilities providing the highest level of care to epilepsy patients and equipped with 24/7 EEG services. The potential of this easy-to-use, cost-effective device to disrupt the slow and cumbersome EEG device space is particularly valuable in the current environment, which has seen an increase in the demand for brain diagnostics as a result of COVID-19.

In addition, emerging research is showing that COVID-19 can cause neurological damage, necessitating brain diagnostic procedures, increasing demand for EEG. Any opportunity to replace inefficient and expensive brain diagnostics procedures with innovative solutions that require less time may ease this built-up pressure.

As an FDA-cleared, easy-to-use, rapid EEG device that can provide results in minutes, the NeuroCap can help bridge that widening gap in the neurological devices market. Committed to closing this gap, Brain Scientific is providing further enhancements of its NeuroCap, including the newest version with velcro adhesions for easier and faster diagnostics, potentially saving time necessary to complete the procedure for each patient. Brain Scientific is dedicated to making the once time-consuming diagnostic process easier for medical staff and more comfortable for patients with each improvement.

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).